Richa Pandey

Dr. Richa Pandey

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
RPRicha Pandey
Richa Pandey
YLYang Lu
Yang Lu
EMErin M. McConnell
Erin M. McConnell
EOEnas Osman
Enas Osman
ASAlexander Scott
Alexander Scott
YLYingfu Li
Yingfu Li

8 November 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
Mohammad JanghorbanMohammad Janghorban
Mohammad Janghorban
IAIrvyne Aradanas
Irvyne Aradanas
SKSara Kazemi
Sara Kazemi
Philippa NgajuPhilippa Ngaju
Philippa Ngaju
RPRicha Pandey
Richa Pandey
Wearable biosensors are becoming increasingly popular due to the rise in demand for non-invasive, real-time monitoring of health and personalized medicine. Traditionally, wearable biosensors have explored protein-based enzymatic and affinity-based detection strategies. However, in the past decade, with the success of nucleic acid-based point-of-care diagnostics, a paradigm shift has been observed in integrating nucleic acid-based assays into wearable sensors, offering better stability, enhanced analytical performance, and better clinical applicability. This narrative review builds upon the current state and advances in utilizing nucleic acid-based assays, including oligonucleotides, nucleic acid, aptamers, and CRISPR-Cas, in wearable biosensing. The review also discusses the three fundamental blocks, i.e., fabrication requirements, biomolecule integration, and transduction mechanism, for creating nucleic acid integrated wearable biosensors.

27 December 2023 in ACS Sensors
Verified
Journal Article
Closed access
MJMohammad Janghorban
Mohammad Janghorban
IAIrvyne Aradanas
Irvyne Aradanas
KMKarem Malaeb
Karem Malaeb
HAHabiba Abuelazm
Habiba Abuelazm
ANAditya Nittala
Aditya Nittala
RPRicha Pandey
Richa Pandey

18 May 2023 in Chemosensors
Verified
Journal Article
Open access
PDF file
Mohammad JanghorbanMohammad Janghorban
Mohammad Janghorban
SKSara Kazemi
Sara Kazemi
RTRigel Tormon
Rigel Tormon
Philippa NgajuPhilippa Ngaju
Philippa Ngaju
RPRicha Pandey
Richa Pandey
The advent of bioprocessing has revolutionized the biomanufacturing industry, leading to the rise of biotherapeutics derived from biologic products such as chimeric antigen receptor (CAR) T-cells used for targeted cancer treatment and the Vero cell line for the production of viral vectors and vaccines. Despite these promising developments, most biologic products are characterized by fragile macromolecular structures that are heterogenous with a purity profile that varies with each batch making them susceptible to microorganism contamination. Regulatory oversight of biologic products is imperative to ensure adherence to good manufacturing practices and compliance with quality management systems. Current quality assurance protocols during production include monoclonality during cell line development, real-time monitoring of process parameters, flow cytometry for microbial monitoring, polymerase chain reaction, and immunoassay techniques to amplify DNA sequences related to bacterial or biological contaminants. FDA guidance recommends the implementation of process analytical technology within biomanufacturing production to measure critical quality parameters, which includes screening for potential biological contamination. Future advancements in bioprocess monitoring and control should capitalize on providing cheap, real-time, and sensitive detection. Biosensors, mass spectrometry, and polymerase chain reaction present robust, rapid, and real-time capabilities for multiplexed detection of contaminant analytes and have shown promise in meeting these needs. This review discusses the main biological contaminants of bioprocesses, European Union and FDA regulatory guidelines for monitoring and control within biologics production, existing methods and their limitations, and future advancements for biological contamination detection.

29 April 2024 in ECS Sensors Plus
Verified
Journal Article
Open access
RPRicha Pandey
Richa Pandey
Cortisol is a key biomarker, and its measurement has historically relied on intrusive and sporadic techniques like blood or saliva samples. The relatively recent innovation of electrochemical cortisol bio-wearables provides a revolutionary strategy by offering continuous, non-invasive monitoring. This Perspective examines the development, underlying ideas, scientific developments, and possible uses of electrochemical cortisol bio-wearables. The significance of these tools for stress research, clinical application, and individualized healthcare is also highlighted.

11 October 2024
Verified
Conference Paper
Open access
SRSutirtha Roy
Sutirtha Roy
MCMoshfiq-Us-Saleheen Chowdhury
Moshfiq-Us-Saleheen Chowdhury
JNJurjaan Onayza Noim
Jurjaan Onayza Noim
RPRicha Pandey
Richa Pandey
ANAditya Shekhar Nittala
Aditya Shekhar Nittala
Sustainable fabrication approaches and biomaterials are increasingly being used in HCI to fabricate interactive devices. However, the majority of the work has focused on integrating electronics. This paper takes a sustainable approach to exploring the fabrication of biochemical sensing devices. Firstly, we contribute a set of biochemical formulations for biological and environmental sensing with bio-sourced and environment-friendly substrate materials. Our formulations are based on a combination of enzymes derived from bacteria and fungi, plant extracts and commercially available chemicals to sense both liquid and gaseous analytes: glucose, lactic acid, pH levels and carbon dioxide. Our novel holographic sensing scheme allows for detecting the presence of analytes and enables quantitative estimation of the analyte levels. We present a set of application scenarios that demonstrate the versatility of our approach and discuss the sustainability aspects, its limitations, and the implications for bio-chemical systems in HCI.